Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.
New Delhi, 5th February 2016: A senior delegation from Wellcome Trust, an independent UK-based global charitable foundation dedicated to improving health, concluded a three-day visit to Hilleman Laboratories.
The 11 member team was given a guided tour of the facilities where they met with Dr. Davinder Gill, CEO and other senior staff members of Hilleman Laboratories. The delegation was also introduced to the current and ongoing projects at Hilleman Laboratories.
Also present were Prof. Gagandeep Kang, Board of Directors, Hilleman Laboratories and Prof. Navin Khanna, ICGEB. In addition, Dr. Gerd Zettlmeissl, Chairman of Board of Directors, Hilleman Laboratories also addressed the delegates.
Dr. Davinder Gill, CEO, Hilleman Laboratories said “We are delighted to host Wellcome Trust as we introduce to them to our Laboratories and the work that we do here. This opportunity to meet the senior members from Wellcome Trust has been very valuable. Through this visit, we have reiterated our ongoing commitment towards the research and development of affordable vaccines to address gaps that exist in the immunization space worldwide.
The Wellcome Trust delegation consisted of representatives of members from the board of governors, executive board and staff: